10x Science

10x Science is dedicated to accelerating biopharmaceutical development to match the rapid advancements in AI-driven drug discovery. The influx of new drug candidates, fueled by AI in the initial stages of discovery, has created a bottleneck in drug development. Existing solutions struggle to handle the complexity and volume of modern drug candidates. 10x Science offers a platform designed to resolve this critical bottleneck.

By integrating advanced AI into the development phase, specifically for protein characterization and quality assessment, 10x Science delivers a comprehensive solution to significantly accelerate and scale the preparation of drug candidates for clinical trials.

The team comprises Stanford University researchers from a Nobel Laureate's laboratory, bringing over 18 years of combined expertise, more than 47 scientific publications, and the experience of a two-time Y Combinator founder. 10x Science is committed to leading the next generation of AI-powered drug development with exceptional speed and innovation.